Endothelial-Cell FAK Targeting Sensitizes Tumours to DNA-damaging Therapy

Nature - United Kingdom
doi 10.1038/nature13541
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

WEE1 Kinase Targeting Combined With DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe

Clinical Cancer Research
Cancer ResearchOncology
2011English

P21(WAF1)-Mediated Transcriptional Targeting of Inducible Nitric Oxide Synthase Gene Therapy Sensitizes Tumours to Fractionated Radiotherapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2006English

Selinexor Reduces the Expression of DNA Damage Repair Proteins and Sensitizes Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2018English

3’-Phosphoadenosine 5’-Phosphosulfate Synthase 1 (PAPSS1) Knockdown Sensitizes Non-Small Cell Lung Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2015English

Targeting Tumor-Intrinsic Hexosamine Biosynthesis Sensitizes Pancreatic Cancer to Anti-Pd1 Therapy

Journal of Clinical Investigation
Medicine
2019English

Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Combating Resistance to DNA Damaging Agents

Oncoscience
Cancer ResearchOncology
2018English

Role of mTOR-Chk1 in Enhancing DNA-damaging Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2015English

Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-Induced Programmed Cell Death

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy